PA5-97117

antibody from Invitrogen Antibodies

Targeting: THBS2 TSP2

Western blot (Data presented on provider website)

Immunohistochemistry (Supportive data in Antibodypedia)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-97117

Provider

Invitrogen Antibodies

Product name

Thrombospondin 2 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Recombinant full-length protein

Description

Sequence of this protein is as follows: MEGPRGWLVL CVLAISLASM VTEDLCRAPD GKKGEAGRPG RRGRPGLKGE QGEPGAPGIR TGIQGLKGDQ GEPGPSGNPG KVGYPGPSGP LGARGIPGIK GTKGSPGNIK DQPRPAFSAI RRNPPMGGNV VIFDTVITNQ EEPYQNHSGR FVCTVPGYYY FTFQVLSQWE ICLSIVSSSR GQVRRSLGFC DTTNKGLFQV VSGGMVLQLQ QGDQVWVEKD PKKGHIYQGS EADSVFSGFL IFPSA

Reactivity

Human, Mouse, Rat

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

0.83 mg/mL

Storage

-20° C, Avoid Freeze/Thaw Cycles

References

Submitted references

Coding transcriptome analyses reveal altered functions underlying immunotolerance of PEG-fused rat sciatic nerve allografts.

Smith TA, Ghergherehchi CL, Tucker HO, Bittner GD
Journal of neuroinflammation 2020 Oct 2;17(1):287

Immunohistochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemistry analysis of Thrombospondin 2 in paraffin-embedded human stomach using Thrombospondin 2 Polyclonal Antibody (Product # PA5-97117) at a dilution of 1:200.

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Fig. 7 Immunohistochemical analyses of cell adhesion and extracellular matrix DEGs. a Fluorescence images showing cross-sections of unoperated control nerve, 14 days PO PEG-fused PNA, and 14 days PO NC PNA immunostained for COL1A1 (green). b Percent (%) COL1A1 staining area comparisons at 14 days PO ( n = 4 per treatment group). c Normalized read counts of COL1A1 RNA transcripts at 14 days PO. Fluorescence images showing immunostaining for CD24 (red) in cross-sections. d Fluorescence images showing immunostaining for CD24 (red). e Percent (%) CD24 staining area comparisons at 14 days PO ( n = 4 per treatment group). f Normalized read counts of CD24 RNA transcripts at 14 days PO. Fluorescence images showing immunostaining for CD24 (red) in cross-sections. g Fluorescence images showing immunostaining for THBS1 (red). h Percent (%) THBS1 staining area comparisons at 14 days PO ( n = 4 per treatment group). i Normalized read counts of THBS1 RNA transcripts at 14 days PO. j Fluorescence images showing immunostaining for THBS2 (red). k Percent (%) THBS2 staining area comparisons at 14 days PO ( n = 4 per treatment group). l Normalized read counts of THBS2 RNA transcripts at 14 days PO. m Fluorescence images showing immunostaining for CD276 (red). n Percent (%) CD276 staining area comparisons at 14 days PO ( n = 4 per treatment group). o Normalized read counts of CD276 RNA transcripts at 14 days PO. Nuclei are stained with DAPI (blue). Scale = 50 mum. In graphs, data are shown as me